Income Statement (TTM)
Rennova Health, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9 | 7 | 5 | 4 | 3 | 3 | 5 | 8 | 10 | 13 | 17 | 20 | 20 | 19 |
| Change (%) | -17.32 | -34.61 | -24.22 | -26.36 | 22.69 | 55.68 | 53.34 | 23.59 | 37.05 | 28.93 | 16.56 | 3.64 | -7.96 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 11 | 12 | 11 | 9 | 8 | 5 | 5 | 5 | 6 | 7 | 7 | 8 | 7 | 8 |
| Change (%) | 8.68 | -9.16 | -13.08 | -17.18 | -31.32 | -4.20 | 5.96 | 11.46 | 13.02 | 7.07 | 3.62 | -0.23 | 1.10 | |
| % of Revenue | 124.50 | 163.66 | 227.34 | 260.76 | 293.27 | 164.16 | 101.01 | 69.80 | 62.95 | 51.92 | 43.11 | 38.33 | 36.90 | 40.54 |
| Gross Operating Profit | -2 | -5 | -6 | -6 | -5 | -2 | -0 | 2 | 4 | 6 | 10 | 12 | 13 | 11 |
| Change (%) | 114.79 | 30.81 | -4.33 | -11.46 | -59.27 | -97.54 | -4,669.07 | 51.63 | 77.87 | 52.53 | 26.36 | 6.03 | -13.27 | |
| % of Revenue | -24.50 | -63.66 | -127.34 | -160.76 | -193.27 | -64.16 | -1.01 | 30.20 | 37.05 | 48.08 | 56.89 | 61.67 | 63.10 | 59.46 |
| SG&A | 12 | 12 | 12 | 11 | 10 | 8 | 6 | 6 | 6 | 7 | 8 | 8 | 9 | 9 |
| Change (%) | -6.45 | -1.22 | -2.55 | -11.07 | -24.79 | -16.23 | -3.59 | -3.45 | 23.28 | 8.80 | 6.09 | 5.59 | 7.25 | |
| % of Revenue | 143.14 | 161.95 | 244.64 | 314.58 | 379.90 | 232.87 | 125.31 | 78.79 | 61.55 | 55.36 | 46.72 | 42.53 | 43.33 | 50.49 |
| R&D | ||||||||||||||
| Change (%) | ||||||||||||||
| % of Revenue | ||||||||||||||
| OpEx | 24 | 24 | 23 | 21 | 19 | 13 | 12 | 12 | 12 | 14 | 16 | 16 | 17 | 17 |
| Change (%) | 1.06 | -4.98 | -7.33 | -12.97 | -27.35 | -11.22 | 0.00 | 3.26 | 17.29 | 7.55 | 4.65 | 2.39 | 3.98 | |
| % of Revenue | 274.35 | 335.35 | 487.30 | 595.91 | 704.20 | 417.00 | 237.78 | 155.07 | 129.56 | 110.88 | 92.49 | 83.04 | 82.04 | 92.69 |
| Operating Income | -15 | -17 | -18 | -18 | -16 | -10 | -7 | -4 | -3 | -1 | 1 | 3 | 4 | 1 |
| Change (%) | 11.60 | 7.61 | -2.96 | -10.28 | -35.63 | -32.33 | -38.71 | -33.67 | -49.55 | -188.95 | 163.25 | 9.75 | -62.54 | |
| % of Revenue | -174.35 | -235.35 | -387.30 | -495.91 | -604.20 | -317.00 | -137.78 | -55.07 | -29.56 | -10.88 | 7.51 | 16.96 | 17.96 | 7.31 |
| Interest Expense | -10 | -10 | -8 | -6 | -4 | -3 | -3 | -2 | -2 | -2 | -2 | -2 | -2 | -1 |
| Change (%) | -5.63 | -20.10 | -22.49 | -27.52 | -27.88 | -9.16 | -14.18 | -3.84 | -5.47 | -3.04 | -2.18 | -5.66 | -28.07 | |
| % of Revenue | -119.74 | -136.67 | -167.00 | -170.80 | -168.10 | -98.82 | -57.66 | -32.27 | -25.11 | -17.32 | -13.02 | -10.93 | -9.95 | -7.77 |
| Net Income | -19 | -18 | -16 | -9 | -2 | 6 | 7 | -2 | -5 | -3 | -0 | 2 | 2 | -8 |
| Change (%) | -2.26 | -10.35 | -42.27 | -79.25 | -384.63 | 29.02 | -132.41 | 114.04 | -34.35 | -93.32 | -810.09 | 50.80 | -428.20 | |
| % of Revenue | -215.47 | -254.71 | -349.21 | -266.03 | -74.94 | 173.86 | 144.08 | -30.45 | -52.73 | -25.26 | -1.31 | 7.97 | 11.60 | -41.36 |
Source: Capital IQ
